Most Recent
Milk supplier Murray Goulburn has been hit with a second class action over its profit forecast revision in 2016 that wiped 40 percent off the dairy cooperative's investment value.
A court has dismissed proceedings filed by cereal giant Sanitarium and sports equipment retailer Rebel Sports against a UK-marketing company over a risk transfer agreement that promised to indemnify the companies for a recent joint promotion campaign.
Building products maker Caesarstone can register two trade marks despite their deceptive similarity to a mark by ceramic tile maker Ceramiche Caesar, a judge has ruled, after finding Caesarstone had shown honest concurrent use of the marks.
The Full Federal Court will hear arguments next week in an appeal by the ACCC over an alleged laundry detergent cartel, the first so-called hub and spoke case brought by the competition regulator.
The ACCC will decide by November 8 whether the proposed merger of Nine Entertainment with Fairfax Media raises competition concerns.
Australian luxury watch retailer Watches of Switzerland has lost a bid to strike out Transport for NSW's defences in a case seeking damages for the ongoing construction of the light rail project in Sydney's CBD.
A judge has set aside an application to block the $48 million sale of a Surfers Paradise building and car park after finding the community organisation that launched the proceedings lacked standing.
A ruling that valued land snatched by the New South Wales government to make way for the massive WestConnex highway at $23 million is invalid because of a Commissioner's involvement in adjudicating the matter, an appeals court has found.
The judge overseeing the competition lawsuit brought by the ACCC over Aurizon's proposed sale of its Queensland intermodal business to Pacific National has denied the regulator's bid for an injunction against Pacific, saying it amounted to micro-managing that could discourage "normal competitive behaviour".
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.